113 related articles for article (PubMed ID: 20829040)
1. A novel arylethynyltriazole acyclonucleoside inhibits proliferation of drug-resistant pancreatic cancer cells.
Wang M; Xia Y; Fan Y; Rocchi P; Qu F; Iovanna JL; Peng L
Bioorg Med Chem Lett; 2010 Oct; 20(20):5979-83. PubMed ID: 20829040
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro anticancer activity of new gemcitabine-nucleoside analogue dimers containing methyltriazole or ester-methyltriazole linker.
Trznadel R; Singh A; Kleczewska N; Liberska J; Ruszkowski P; Celewicz L
Bioorg Med Chem Lett; 2019 Sep; 29(18):2587-2594. PubMed ID: 31400940
[TBL] [Abstract][Full Text] [Related]
3. A novel bitriazolyl acyclonucleoside endowed with dual antiproliferative and immunomodulatory activity.
Xia Y; Wang M; Demaria O; Tang J; Rocchi P; Qu F; Iovanna JL; Alexopoulou L; Peng L
J Med Chem; 2012 Jun; 55(11):5642-6. PubMed ID: 22578090
[TBL] [Abstract][Full Text] [Related]
4. Introducing of acyclonucleoside analogues tethered 1,2,4-triazole as anticancer agents with dual epidermal growth factor receptor kinase and microtubule inhibitors.
Aouad MR; Al-Mohammadi HM; Al-Blewi FF; Ihmaid S; Elbadawy HM; Althagfan SS; Rezki N
Bioorg Chem; 2020 Jan; 94():103446. PubMed ID: 31791685
[TBL] [Abstract][Full Text] [Related]
5. Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway.
Wang X; Wu X; Zhang Z; Ma C; Wu T; Tang S; Zeng Z; Huang S; Gong C; Yuan C; Zhang L; Feng Y; Huang B; Liu W; Zhang B; Shen Y; Luo W; Wang X; Liu B; Lei Y; Ye Z; Zhao L; Cao D; Yang L; Chen X; Haydon RC; Luu HH; Peng B; Liu X; He TC
Sci Rep; 2018 Dec; 8(1):17914. PubMed ID: 30559409
[TBL] [Abstract][Full Text] [Related]
6. Novel triazole ribonucleoside down-regulates heat shock protein 27 and induces potent anticancer activity on drug-resistant pancreatic cancer.
Xia Y; Liu Y; Wan J; Wang M; Rocchi P; Qu F; Iovanna JL; Peng L
J Med Chem; 2009 Oct; 52(19):6083-96. PubMed ID: 19754200
[TBL] [Abstract][Full Text] [Related]
7. Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells.
Cascioferro S; Petri GL; Parrino B; Carbone D; Funel N; Bergonzini C; Mantini G; Dekker H; Geerke D; Peters GJ; Cirrincione G; Giovannetti E; Diana P
Eur J Med Chem; 2020 Mar; 189():112088. PubMed ID: 32007666
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.
Bocci G; Fioravanti A; Orlandi P; Bernardini N; Collecchi P; Del Tacca M; Danesi R
Br J Cancer; 2005 Aug; 93(3):319-30. PubMed ID: 16052215
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype.
Hu G; Li F; Ouyang K; Xie F; Tang X; Wang K; Han S; Jiang Z; Zhu M; Wen D; Qin X; Zhang L
Int J Oncol; 2012 Mar; 40(3):798-806. PubMed ID: 22076649
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel arylethynyltriazole ribonucleosides with selective and effective antiviral and antiproliferative activity.
Wan J; Xia Y; Liu Y; Wang M; Rocchi P; Yao J; Qu F; Neyts J; Iovanna JL; Peng L
J Med Chem; 2009 Feb; 52(4):1144-55. PubMed ID: 19170598
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression.
Guo Z; Wang F; Di Y; Yao L; Yu X; Fu D; Li J; Jin C
Int J Nanomedicine; 2018; 13():4869-4880. PubMed ID: 30214194
[TBL] [Abstract][Full Text] [Related]
12. Everolimus and mycophenolate mofetil sensitize human pancreatic cancer cells to gemcitabine in vitro: a novel adjunct to standard chemotherapy?
Tuncyurek P; Mayer JM; Klug F; Dillmann S; Henne-Bruns D; Keller F; Stracke S
Eur Surg Res; 2007; 39(6):380-7. PubMed ID: 17700025
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.
Bao B; Ali S; Kong D; Sarkar SH; Wang Z; Banerjee S; Aboukameel A; Padhye S; Philip PA; Sarkar FH
PLoS One; 2011 Mar; 6(3):e17850. PubMed ID: 21408027
[TBL] [Abstract][Full Text] [Related]
14. Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer.
Kazim S; Malafa MP; Coppola D; Husain K; Zibadi S; Kashyap T; Crochiere M; Landesman Y; Rashal T; Sullivan DM; Mahipal A
Mol Cancer Ther; 2015 Jul; 14(7):1570-81. PubMed ID: 25934708
[TBL] [Abstract][Full Text] [Related]
15. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis.
Subramaniam D; Periyasamy G; Ponnurangam S; Chakrabarti D; Sugumar A; Padigaru M; Weir SJ; Balakrishnan A; Sharma S; Anant S
Mol Cancer Ther; 2012 Jul; 11(7):1598-608. PubMed ID: 22532602
[TBL] [Abstract][Full Text] [Related]
16. Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells.
Muralidharan-Chari V; Kohan HG; Asimakopoulos AG; Sudha T; Sell S; Kannan K; Boroujerdi M; Davis PJ; Mousa SA
Oncotarget; 2016 Aug; 7(31):50365-50379. PubMed ID: 27391262
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy.
Arya G; Vandana M; Acharya S; Sahoo SK
Nanomedicine; 2011 Dec; 7(6):859-70. PubMed ID: 21550422
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of all-trans retinoic acid and its synergism with gemcitabine are associated with downregulation of p21-activated kinases in pancreatic cancer.
Wang K; Baldwin GS; Nikfarjam M; He H
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G632-G640. PubMed ID: 30844294
[TBL] [Abstract][Full Text] [Related]
19. Arylethynyltriazole acyclonucleosides inhibit hepatitis C virus replication.
Zhu R; Wang M; Xia Y; Qu F; Neyts J; Peng L
Bioorg Med Chem Lett; 2008 Jun; 18(11):3321-7. PubMed ID: 18445526
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cancer cell growth in gemcitabine-resistant pancreatic carcinoma by mangiferin phytochemical involves induction of autophagy, endogenous ROS production, cell cycle disruption, mitochondrial mediated apoptosis and suppression of cancer cell migration and invasion.
Yu L; Chen M; Zhang R; Jin Z
J BUON; 2019; 24(4):1581-1586. PubMed ID: 31646812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]